U.S. company assumes control of Outlook salesPicker Nordstar, the novel manufacturing/marketing joint venturebetween Picker International and Instrumentarium Imaging in Helsinki,Finland, took an unexpected turn in late March when
Picker Nordstar, the novel manufacturing/marketing joint venturebetween Picker International and Instrumentarium Imaging in Helsinki,Finland, took an unexpected turn in late March when Cleveland-basedPicker bought its partner's shares in the venture.
Operations associated with the 0.23-tesla Outlook, an open-architectureMRI scanner designed and manufactured by Nordstar and marketedby Picker, have been integrated into Picker's MRI division. PickerNordstar will remain headquartered in Helsinki.
Outlook was introduced at the 1994 Radiological Society ofNorth America meeting (SCAN 11/23/94). The scanner is an iron-coreresistive magnet system that employs a technology called electronspin resonance (ESR) to achieve a more stable magnetic field.
Picker and Instrumentarium formed the Nordstar joint venturein 1993 (SCAN 2/10/93). The deal marked Picker's return to thelow-field segment by allowing it to take over sales of Instrumentarium'sMerit 0.1-tesla scanner, as well as MRI R&D technology underdevelopment at Instrumentarium, such as Overhauser MRI. Meritis still being sold, primarily in international markets.
Picker's buyout of Instrumentarium's share of Nordstar is acontinuation of Picker's strategy in the MRI market and will boostthe vendor's prospects in Europe, according to Linda Eastwood,MR group manager.
"It gives us the benefit of working together far moreclosely and it gives us a new base in Europe," she said.
Picker gained complete control over Outlook and the Helsinki-basedengineering group responsible for its development. Robert Gyllingwill continue to manage Nordstar under the new Picker ownership,Eastwood said.
The deal does not affect a separate marketing and manufacturingagreement that assigned Picker the rights to sell Neuromag-122,a magnetoencephalography system. Nordstar will continue to providesome manufacturing and Picker will continue to sell products forthe company, Eastwood said.
Outlook scanner owners will not notice any differences becauseof the ownership change, according to Eastwood.
"The customers were already buying from Picker. It isa Picker product. It is just more fully a Picker product now,"she said.
Seven Takeaways from Meta-Analysis of PSMA Radiotracers for Prostate Cancer Imaging
December 1st 2023In a newly published meta-analysis of 24 studies, researchers noted that the PSMA PET radiotracer 18F PSMA-1007 may provide more benefit than 68Ga Ga-PSMA-11 for primary staging of patients with prostate cancer and detection of local lesion recurrence, but also has drawbacks with higher liver uptake and multiple reports of false positive bone lesions.
Study: Regular Mammography Screening Reduces Breast Cancer Mortality Risk by More than 70 Percent
November 30th 2023Consistent adherence to the five most recent mammography screenings prior to a breast cancer diagnosis reduced breast cancer death risk by 72 percent in comparison to women who did not have the mammography screening, according to new research findings presented at the annual Radiological Society of North America (RSNA) conference.
Chest CT Study Shows Higher Emphysema Risk from Combination of Marijuana and Cigarette Smoking
November 28th 2023People who smoke marijuana and cigarettes have 12 times the risk for centrilobular emphysema than non-smokers, according to new computed tomography (CT) research presented at the annual Radiological Society of North America (RSNA) conference.
Seven Takeaways from Meta-Analysis of PSMA Radiotracers for Prostate Cancer Imaging
December 1st 2023In a newly published meta-analysis of 24 studies, researchers noted that the PSMA PET radiotracer 18F PSMA-1007 may provide more benefit than 68Ga Ga-PSMA-11 for primary staging of patients with prostate cancer and detection of local lesion recurrence, but also has drawbacks with higher liver uptake and multiple reports of false positive bone lesions.
Study: Regular Mammography Screening Reduces Breast Cancer Mortality Risk by More than 70 Percent
November 30th 2023Consistent adherence to the five most recent mammography screenings prior to a breast cancer diagnosis reduced breast cancer death risk by 72 percent in comparison to women who did not have the mammography screening, according to new research findings presented at the annual Radiological Society of North America (RSNA) conference.
Chest CT Study Shows Higher Emphysema Risk from Combination of Marijuana and Cigarette Smoking
November 28th 2023People who smoke marijuana and cigarettes have 12 times the risk for centrilobular emphysema than non-smokers, according to new computed tomography (CT) research presented at the annual Radiological Society of North America (RSNA) conference.
2 Clarke Drive
Cranbury, NJ 08512